---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-001502"
form_type: "8-K"
ticker: "REVB"
cik: "0001810560"
company_name: "REVELATION BIOSCIENCES, INC."
filed_at: "2023-01-31T23:59:59+00:00"
generated_at: "2026-06-20T05:36:38.766623+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Revelation Biosciences announces 1-for-35 reverse stock split effective Feb 1, 2023

## Summary
- Reverse split reduces outstanding shares from ~23.5M to ~672,460 shares.
- Authorized common stock increased from 100M to 500M shares via charter amendment.
- Split intended to regain Nasdaq minimum bid compliance; new CUSIP 76135L 309.
- Stockholders also ratified Baker Tilly US, LLP as auditor for FY 2023.
- Proportionate adjustments applied to warrants, options, and equity awards.

## SEC filing metadata
- accession: 0000950170-23-001502
- form_type: 8-K
- ticker: REVB
- cik: 0001810560
- company_name: REVELATION BIOSCIENCES, INC.
- filed_at: 2023-01-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810560/000095017023001502/0000950170-23-001502-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810560/000095017023001502/revb-20230130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-001502
- JSON: https://secwatch.observer/filing/0000950170-23-001502.json
- Plain text: https://secwatch.observer/filing/0000950170-23-001502.txt

## Key facts
- Governance Changes
  REVELATION BIOSCIENCES, INC.: Amended certificate of incorporation to increase authorized common shares from 100,000,000 to 500,000,000 and effect a 1-for-35 reverse stock split (effective 2023-02-01).
  - Change: charter amendment
  - Effective: 2023-02-01
  source text: On January 30, 2023, the Company filed a Certificate of Amendment of Third Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) reflecting the change in authorized shares of common stock from 100,000,000 to 500,000,000 and effecting a reverse stock split as of 12:01 a.m. Eastern Standard Time on February 1, 2023 with a ratio of 1-for-35
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810560/000095017023001502/0000950170-23-001502-index.htm
- Shareholder Votes
  REVELATION BIOSCIENCES, INC. shareholders approved Reverse Stock Split at the 2023-01-30 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-01-30
  source text: Proposal 2 – Reverse Stock Split Stockholders approved the board of directors to effect a Reverse Stock Split of the outstanding shares of our common stock within one (1) year of January 30, 2023, at a specific ratio within a range of one-for-twenty (1-for-20) to a maximum of a one-for-one hundred (1-for-100) split, with the specific ratio to be fixed within this range by the board of directors in its sole discretion without further stockholder approval, based on the votes listed below: For Against Abstain 56,353,405 3,599,118 3,125,315
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810560/000095017023001502/0000950170-23-001502-index.htm
- Shareholder Votes
  REVELATION BIOSCIENCES, INC. shareholders approved Ratification of the Auditor at the 2023-12-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-12-31
  source text: Proposal 3 – Ratification of the Auditor Stockholders approved Baker Tilly US, LLP to audit our financial statements for the fiscal year ending December 31, 2023, based on the votes listed below: For Against Abstain 12,219,710 274,018 584,110
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810560/000095017023001502/0000950170-23-001502-index.htm
- Shareholder Votes
  REVELATION BIOSCIENCES, INC. shareholders approved Increase in the Number of Shares of Authorized Common Stock.
  - Proposal: charter amendment
  - Outcome: passed
  source text: Proposal 1 – Increase in the Number of Shares of Authorized Common Stock Stockholders approved the amendment to increase the number of authorized common stock from 100,000,000 to 500,000,000 shares, based on the votes listed below: For Against Abstain 53,329,345 6,506,571 3,241,922
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810560/000095017023001502/0000950170-23-001502-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.